BETA BIONICS, INC.: latest developments and connections

What's happening

Reports per dayLast 90 days

90 days agoDrag either end to show only events that began in that periodToday

Earlier this month

Beta Bionics, Inc. is accused of failing to accurately describe observations made by the FDA.

Some support16 reports1 development inside
BETA BIONICS, INC. is subject to a securities class action lawsuit.

Well supported4 reports

One to three months ago

FDA issued a Form 483 after inspecting Beta Bionics, while Josh Wilson represented investors in a class action suit.

Some support2 reports
Beta Bionics received FDA clearance for its iLet Bionic Pancreas device on August 21, 2025.

Well supported4 reports1 development inside
FDA released a warning letter regarding device failures involving Beta Bionics, Inc.

Well supported4 reports
Lawsuit filed by Beta Bionics, Inc. in the Central District of California.

Well supported10 reports

Gone quiet

No new reports in 90+ days

Around BETA BIONICS, INC. this week

News at the entities that move BETA BIONICS, INC. most

FDA Structural
The FDA is involved in regulating drug approvals for GLP-1 Receptor Agonists.

Moves BETA BIONICS, INC.
13:39
SEC Structural
Arcutis Biotherapeutics, Inc. disclosed an executive stock sale via a filing with the SEC on November 11, 2026.

Moves BETA BIONICS, INC.
13:29
Wells Fargo Mentioned together
Grocery Outlet CEO Potter highlighted operational changes for performance on August 13, 2025, while a Wells Fargo analyst questioned comp acceleration drivers.

Moves BETA BIONICS, INC.
00:52
Truist Financial Transactional
Truist, Zacks, and Goldman Sachs issued rating and price target updates for People Incorporated Common Stock.

Moves BETA BIONICS, INC.
10:15
California Shared context
Duncan seeks economic relief for constituents while Strickland and Ta face off against Duncan and Swift in recent political races.

Moves BETA BIONICS, INC.
06:51
New York City Shared context
Abby Livingston joins MS NOW as a political reporter and will be based in New York City.

Moves BETA BIONICS, INC.
07:36

Connections

The 14 strongest of 23, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.

FDA Structural

The FDA formally regulates Beta Bionics, issuing clearances, Form 483s, and warning letters regarding device safety and reporting.

Well supportedOct 28

BETA BIONICS, INC. → FDA
FDA → BETA BIONICS, INC.
SEC Structural

Beta Bionics operates under the mandatory regulatory oversight and filing requirements of the U.S. Securities and Exchange Commission.

Some supportSep 25

BETA BIONICS, INC. → SEC
SEC → BETA BIONICS, INC.
Josh Wilson Structural

Josh Wilson serves as legal counsel representing investors in a class action lawsuit involving Beta Bionics.

Some supportSep 25

BETA BIONICS, INC. → Josh Wilson
Josh Wilson → BETA BIONICS, INC.
Truist Financial Transactional

Truist Financial assessed BETA Bionics, Inc. by adjusting its price targets and providing analyst coverage.

Some supportSep 25

BETA BIONICS, INC. → Truist Financial
Truist Financial → BETA BIONICS, INC.
Ilet Structural

BETA BIONICS manufactures the iLet Bionic Pancreas, utilizing the location Ilet for its operations.

Some supportSep 16

BETA BIONICS, INC. → Ilet
Ilet → BETA BIONICS, INC.
California Shared context

BETA BIONICS, INC. is involved in legal actions and class suits within the jurisdiction of California.

Well supportedNov 2

BETA BIONICS, INC. → California
California → BETA BIONICS, INC.
Central District Shared context

A lawsuit involving BETA BIONICS, INC. is pending within the jurisdiction of the Central District.

Well supportedOct 30

BETA BIONICS, INC. → Central District
Central District → BETA BIONICS, INC.
Wells Fargo Mentioned together

Wells Fargo provides market visibility and analyst coverage for Beta Bionics.

Some supportSep 25

BETA BIONICS, INC. → Wells Fargo
Wells Fargo → BETA BIONICS, INC.

Show all 14 connections

New York Shared context

The company is involved in a securities class action, placing it within the context of New York's financial environment.

Some supportOct 23

BETA BIONICS, INC. → New York
New York → BETA BIONICS, INC.
New York City Shared context

A lawsuit involving BETA BIONICS, INC. was filed within the jurisdiction of New York City.

Some supportOct 15

BETA BIONICS, INC. → New York City
New York City → BETA BIONICS, INC.
New York Shared context

BETA BIONICS, INC. is involved in a lawsuit taking place within the jurisdiction of New York.

Some supportNov 1

BETA BIONICS, INC. → New York
New York → BETA BIONICS, INC.
company Transactional

BETA BIONICS filed a class action on behalf of purchasers.

Some supportOct 8

BETA BIONICS, INC. → company
company → BETA BIONICS, INC.
Irvine Shared context

Beta Bionics is headquartered and reports financial results from the location of Irvine.

SpeculativeJul 30

BETA BIONICS, INC. → Irvine
Irvine → BETA BIONICS, INC.
Phillip Kim Mentioned together

No direct relationship between Phillip Kim and BETA BIONICS, INC. is supported by the evidence.

Some supportOct 24

BETA BIONICS, INC. → Phillip Kim
Phillip Kim → BETA BIONICS, INC.

History

Events by the month they began

October 2026

1 event

Oct 23, 2026BETA BIONICS, INC. is subject to a securities class action lawsuit.

September 2026

4 events

June 2026

3 events